Cellectar Biosciences Inc (NASDAQ:CLRB) shares, rose in value, with the stock price up by 0.33% to the previous day’s close as strong demand from buyers drove the stock to $3.03.
Actively observing the price movement in the last trading, the stock closed the session at $3.02. Referring to stock’s 52-week performance, its high was $4.45, and the low was $1.33. On the whole, CLRB has fluctuated by -16.64% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CLRB’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CLRB currently trading nearly -13.29% and -16.49% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 36.49, while the 7-day volatility ratio is showing 6.09% which for the 30-day chart, stands at 6.19%. Furthermore, Cellectar Biosciences Inc (CLRB)’s beta value is 0.99, and its average true range (ATR) is 0.22.
A comparison of Cellectar Biosciences Inc (CLRB) with its peers suggests the former has fared considerably weaker in the market. CLRB showed an intraday change of 0.33% in last session, and over the past year, it grew by 107.39%%.
Data on historical trading for Cellectar Biosciences Inc (NASDAQ:CLRB) indicates that the trading volumes over the past 3 months, they’ve averaged 1.09 million. According to company’s latest data on outstanding shares, there are 32.26 million shares outstanding.
Nearly 9.42% of Cellectar Biosciences Inc’s shares belong to company insiders and institutional investors own 26.30% of the company’s shares. The stock has risen by 9.39% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CLRB stock heading into the next quarter.
